Location: Home
  • search
  • go
  • Relate News
  • 6/14/2025Keymed Biosciences' BsAb Shows Promise in Autoimmune Hemolytic Anemia
  • 6/14/2025Tianjin Slaps CNY 362M Fine for Drug Price-Fixing Scheme
  • 6/13/2025Kelun Cleared for Clinical Trial of SKB315 and Tagitanlimab Combo in C...
  • 6/13/2025Nona and Visterra Partner to Advance Next-Gen Biotherapeutics for Immu...
  • 6/13/2025AstraZeneca Enters Strategic Deal with CSPC Pharma Focused on AI-enabl...
  • 6/13/2025AB‑RayBio Secures Multi‑Million CNY Angel Investment
  • 6/13/2025Abbisko Therapeutics' Pimicotinib Earns NMPA Nod for TGCT NDA Review
  • 6/13/2025China Issues 2025 Action Plan to Combat Malpractice in Pharma Procure...
  • 6/13/2025Recent Executive Moves
  • 6/12/2025InnoVec Raises Tens of Millions in Series A+ to Accelerate Gene Therap...
  • 6/12/2025Cloudbreak Advances Ophthalmic Pipeline, Pursues Hong Kong IPO
  • 6/12/2025Dizal to Showcase Breakthrough Data on Hematologic Oncology Assets at ...
  • 6/12/2025CF PharmaTech Files for Hong Kong IPO
  • 6/12/2025Hengrui Advances DLL3‑Targeting ADC SHR‑4849 with Phase II China Tri...
  • 6/12/2025Viatris Wins NMPA Approval for Once‑Daily Nebulized COPD Therapy Yupe...
  • 6/12/2025China's AI Healthcare Market (Part I): Growth Trends, Drivers, and APA...
  • 6/12/2025China's AI Healthcare Market (Part II): Opportunities and Strategies f...
  • 6/11/20253Sbio Powers Ahead in PD-1/VEGF Bispecific Race with Impressive Phase ...
  • 6/11/2025Ligachem Inks Dual ADC Licensing Deals with CSPC Subsidiary Novarock
  • 6/11/2025JW Pharma Wins China Approval for Ertapenem Injection
  • 6/11/2025MediLink Therapeutics Lines Up Major Banks for Hong Kong IPO Push
  • 6/10/2025GenEditBio Doses First Patient in World’s First In Vivo CRISPR Trial ...
  • 6/10/2025Innogen Pharma Files for Hong Kong Listing, Accelerates Pipeline Devel...
  • 6/10/2025Green Valley Halts Sales of Alzheimer's Drug GV-971 Amid Regulatory Un...
  • 6/10/2025Transpire Enters License Deal with Intragrand Pharma for Investigation...
  • 6/10/2025CDE Seeks Public Feedback on Second Batch of 2025 External Expert Addi...
  • 6/10/2025CDE Seeks Comments on Draft Guidelines for Defining and Classifying Ad...
  • 6/10/2025NH's DB6: China's Consumer Healthcare Market Underperformed Again in 2...
  • 6/10/2025Merck’s Pimicotinib NDA Accepted by CDE in China, Setting Course for ...
  • 6/10/2025Gavi Launches $224M Arbitration Claim Against Clover Biopharma Over CO...
  • Page:1/771 Total number of articles:23130: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group